| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.006 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.007 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.16 | 0.02 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |